273 related articles for article (PubMed ID: 30503890)
1. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
[TBL] [Abstract][Full Text] [Related]
2. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients.
Grinnell M; Appiah AK; Baine M; Ernani V; Marr A; Zhang C; Zhen W; Buddharaju LNR; Smith LM; Ganti AK
J Geriatr Oncol; 2020 Sep; 11(7):1145-1153. PubMed ID: 32389520
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
5. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
6. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
[TBL] [Abstract][Full Text] [Related]
8. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.
Samson P; Rehman S; Juloori A; DeWees T; Roach M; Bradley J; Videtic GMM; Stephans K; Robinson C
Pract Radiat Oncol; 2018; 8(6):404-413. PubMed ID: 29907514
[TBL] [Abstract][Full Text] [Related]
9. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
[TBL] [Abstract][Full Text] [Related]
10. It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival.
Roach MC; Rehman S; DeWees TA; Abraham CD; Bradley JD; Robinson CG
Pract Radiat Oncol; 2016; 6(1):12-8. PubMed ID: 26598909
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
13. Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC.
Steber CR; Hughes RT; Soike MH; Jacobson T; Helis CA; Farris JC; Farris MK
Clin Lung Cancer; 2021 Jan; 22(1):e122-e131. PubMed ID: 33046359
[TBL] [Abstract][Full Text] [Related]
14. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
Chen Y; Guo W; Lu Y; Zou B
Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
16. Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.
Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
Clin Lung Cancer; 2017 Mar; 18(2):e137-e142. PubMed ID: 27908620
[TBL] [Abstract][Full Text] [Related]
17. Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
Fischer-Valuck BW; Boggs H; Katz S; Durci M; Acharya S; Rosen LR
Tumori; 2015; 101(3):287-93. PubMed ID: 25908031
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib combined with stereotactic radiosurgery in previously treated patients with advanced non-small cell lung cancer.
Wang Z; Zhu XX; Wu XH; Li B; Shen TZ; Kong QT; Li J; Liu ZB; Jiang WR; Wang Y; Hou B
Am J Clin Oncol; 2014 Apr; 37(2):148-53. PubMed ID: 23211223
[TBL] [Abstract][Full Text] [Related]
19. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
[TBL] [Abstract][Full Text] [Related]
20. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall.
Gao SJ; Corso CD; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
Clin Lung Cancer; 2017 Mar; 18(2):169-177.e4. PubMed ID: 27890561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
